AI-Enhanced NMR Spectroscopy Services

From Solution-State Sample to Dynamic Structural Ensemble — AI-Accelerated.
ML-Assisted Assignment STD-NMR Fragment Screening Solution Structures & Dynamics

NMR captures conformational dynamics, binding epitopes, and weak fragment interactions in native solution — data that static methods miss. Our AI-driven platform compresses assignment and screening timelines from months to weeks, with direct handoff to Molecular Dynamics (MD) Simulations and Fragment-based Screening.

Creative Biostructure at a Glance

600+ NMR structures & spectra delivered
<1 Week Typical STD-NMR screening turnaround
6–10 Weeks Full structure determination

Over a decade of trusted expertise powering biotech, pharma, and research institutions worldwide to advance therapeutic innovation.

abbvie
novartis
amgen
gsk
regeneron
sanofi

Why Partner With Us

Most NMR structural biology programs stall at the assignment stage. A single NOESY spectrum can harbor thousands of cross-peaks, and manual interpretation consumes months of spectroscopist time. Virtual biotechs cannot justify the $5M+ CapEx of an 800 MHz magnet, cryoprobe, and isotope-labeling infrastructure. Pharma teams often split protein production, isotope labeling, and data interpretation across vendors — losing the continuity required to link chemical shifts to binding mechanisms. We built this platform to eliminate that friction: one team where AI-driven assignment, automated structure calculation, and fragment screening share the same milestone clock.

Your CapEx is in compute and chemistry. Ours is in high-field magnets and isotope-labeling expertise.

Stage What We Deliver What You Don't Need to Build
AI Expression Design AlphaFold3-guided construct boundaries; isotope-labeling strategy (¹³C/¹⁵N, ²H, selective methyl) Molecular biology team
Isotope-Labeled Production E. coli or yeast expression in minimal media; Target Protein Production Fermentation suite
AI-Accelerated Data Collection Non-uniform sampling (NUS) with ML reconstruction; automated multidimensional experiments (HSQC, NOESY, TROSY) NMR facility
ML-Guided Assignment & Structure Deep learning peak picking; automated NOESY assignment; CYANA/CNS structure calculation Bioinformatics team
Dynamic Handoff Ensemble structures + relaxation data directly to MD or Hit Biophysical Characterization

Production-Ready Deliverables: Every project ships with BMRB deposition-ready chemical shift lists, PDB-format structural ensembles, relaxation/dynamics reports, and direct handoff to Molecular Docking or Lead Optimization.

  • Milestone-based pricing aligned with your fundraising cycles
  • No vendor coordination overhead — isotope labeling, data collection, assignment, and structure under a single project manager

Intrinsically disordered proteins. Allosteric pockets. Weak fragment binders. "Undruggable" is our starting point.

Proven track record where others fail

IDPs, peptide hormones, nucleic acid-binding domains, and allosteric regulatory proteins — targets that evade crystallization due to flexibility or lack of diffracting crystals.

Multi-modal pivot capability

When NOESY data are sparse, we deploy AlphaFold-NMR conformer selection; when targets exceed 50 kDa, we switch to methyl-TROSY or segmental isotope labeling without restarting the project clock.

IP firewall & encrypted data infrastructure

Full audit trails, GLP-ready documentation, client retains 100% ownership of all spectral data, assignments, and structural ensembles.

Core Service Modules

Service Module At-a-Glance

Service Core Capability Structural + Computational Integration Typical Timeline
Fragment Screening by NMR (STD-NMR) Weak-affinity fragment detection; hit validation; binding epitope mapping ML-boosted SHARPER NMR for rapid K_D determination; chemical shift perturbation mapping; integration with FBDD 1–2 weeks
Protein Structure Determination by NMR Solution-state structures; conformational ensembles; μs–ms dynamics AI-assisted resonance assignment (ARTINA); automated NOESY analysis; AlphaFold3-guided initial models; handoff to MD 6–10 weeks

Fragment Screening by NMR (STD-NMR)

Detecting Weak Binders That Other Miss

STD-NMR difference spectrum revealing fragment binding to a target protein.

Key Features:

  • Saturation Transfer Difference (STD) NMR — Detects fragment binding at millimolar affinities that evade SPR or ITC, with binding epitope information encoded in differential signal attenuation.
  • ML-Boosted SHARPER NMR — Machine learning models rank fragment affinities from just two titration points, enabling 144 K_D determinations per day on a 600 MHz QCI cryoprobe — versus a handful by conventional titration methods.
  • Chemical Shift Perturbation (CSP) Mapping — ¹H-¹⁵N HSQC titrations pinpoint ligand binding sites at residue-level resolution, guiding medicinal chemistry optimization.
  • Orthogonal Validation — STD-NMR hits are cross-validated with DLS (aggregation control) and TSA (thermal stabilization) before progression to co-crystallization.

What We Offer: For Fragment-based Drug Discovery programs, STD-NMR provides the first experimental evidence of ligand-protein contact — critical for prioritizing hits before X-ray or Cryo-EM structure validation. For virtual biotechs, our 96-position SampleJet automation eliminates the need for on-site NMR operators.

Protein Structure Determination by NMR

Solution-State Structures in Conformational Ensemble

2D HSQC spectrum showing protein backbone resonance assignments with AI-predicted chemical shift overlay.

Key Features:

  • AI-Accelerated Resonance Assignment — ARTINA deep learning (ResNet peak picking + GNN chemical shift refinement) automates backbone and side-chain assignment, reducing the bottleneck from months to days.
  • Automated NOESY Analysis — ML-guided cross-peak deconvolution and distance restraint generation feed directly into CYANA/CNS structure calculation.
  • AlphaFold-NMR Conformer SelectionAlphaFold3 ensembles are scored against experimental chemical shifts and NOESY data, identifying hidden conformational states invisible to restraint-satisfaction protocols alone.
  • Dynamics Characterization — R₁, R₂, heteronuclear NOE, and CPMG relaxation dispersion quantify μs–ms motions — data that static X-ray or Cryo-EM structures cannot capture.

What We Offer: For peptide therapeutics and intrinsically disordered proteins, NMR delivers the ensemble-averaged structures and dynamic landscapes required for rational drug design. For allosteric drug discovery, relaxation data reveal cryptic pocket opening events.

Technology Platform

Integrated NMR Infrastructure: AI Assignment + Isotope Labeling + Structure Calculation, Zero Handoffs

Traditional NMR splits isotope labeling, data collection, and interpretation across separate groups — losing critical chemical context at every transfer. Our platform unifies all stages under one project team, with AI predictions informing pulse sequence selection and experimental chemical shifts feeding back into model training.

Computational Platform — Dry Lab

Capability Details
AI Assignment Engine ARTINA (ResNet peak picking + GNN shift refinement + GBT structure ranking); NMRNet SE(3) Transformer for ¹H/¹³C/¹⁵N chemical shift prediction
AlphaFold-NMR Integration Conformer selection from AlphaFold3 ensembles against experimental shifts and NOESY data; multistate ensemble fitting
Automated Structure Calculation CYANA/CNS with AI-generated distance and dihedral restraints; TALOS-N secondary structure prediction; MolProbity validation
Fragment Scoring ML ML-boosted 1H LB SHARPER NMR for rapid affinity ranking from sparse titration data
Dynamics Analysis Automated relaxation curve fitting (R₁, R₂, NOE); CPMG dispersion analysis for μs–ms kinetics

Experimental NMR Platform — Wet Lab

Capability Details
High-Field NMR Bruker Avance NEO 600 MHz and 800 MHz spectrometers; QCI cryoprobes (¹H/¹³C/¹⁵N/²H quadruple-resonance)
Automation SampleJet 96-position automatic sample changer; IconNMR for unattended overnight multidimensional acquisition
Isotope Labeling ¹³C/¹⁵N uniform labeling in minimal media; ²H back-exchange for proteins >30 kDa; selective ILV-methyl labeling
Advanced Experiments TROSY for large complexes; BEST/CRINEPT for very large systems; ¹⁹F-NMR for ligand screening and dynamics
Micro-Scale Sensitivity 1.7 mm microprobe and CryoProbe QCI (4K) delivering 4–5× sensitivity gain over room-temperature probes
Bruker Avance NEO 800 MHz

Bruker Avance NEO 800 MHz

MicroCal PEAQ-ITC

MicroCal PEAQ-ITC

Waters AutoPurification System

Waters AutoPurification System

Shimadzu LC-20AP Prep-HPLC

Shimadzu LC-20AP Prep-HPLC


Platform Edge: The ability to express a ¹³C/¹⁵N-labeled sample on Monday, collect HSQC and NOESY data overnight on Tuesday, and deliver AI-assisted assignments by Thursday — all under one project team — compresses traditional 4-month NMR structure determination into 6-week iterations.

Platform specifications are subject to continuous upgrade. Contact our team for instrument availability and project-specific capability assessment.

Closed-Loop Discovery Engine

When AI Prediction Meets Chemical Shift Truth

Static AI models predict single-state structures from sequence. Experimental NMR reveals the dynamic reality that models miss — conformational exchange, invisible states, and ligand-induced population shifts. Our platform feeds every spectral dataset back into the design cycle.

01

AI Chemical Shift Prediction

NMRNet predicts ¹H/¹³C/¹⁵N shifts from sequence; deviations flag dynamic regions and assignment priorities for experimental focus

→ Feeds into Assignment

02

ML-Accelerated Assignment

ARTINA automates peak picking and resonance assignment; NOESY cross-peaks assigned with AI confidence scores

→ Feeds into Structure

03

Ensemble Structure & Dynamics

NMR-derived restraints + AlphaFold3 models generate conformational ensembles; relaxation data refine binding site plasticity

→ Feeds into CADD

04

Structural Feedback

Experimental chemical shifts and NOESY patterns retrain target-specific shift predictors, improving next-campaign accuracy

→ Feeds back into AI

Industrial Value:

For Biotechs

Your first NMR assignment trains the AI models for your second target. Chemical shift and dynamics data from Phase 0 become training data for Phase 1 — a compounding learning partnership.

For Pharma

Every computational prediction is linked to an experimental outcome with project ID, timestamp, and model version — fully audit-ready for regulatory submissions and internal portfolio reviews.

Project Management & Execution

Project Workflow

A standardized, milestone-driven execution system. From sequence intake to deposition-ready coordinates.

01 Expression & Labeling Week 1
02 Purification & QC Weeks 1–2
03 Data Collection Weeks 2–4
04 AI Assignment Weeks 4–5
05 Structure/Dynamics Weeks 5–7
06 Validation & Handoff Weeks 7–8

01 Expression & Labeling

  • AlphaFold3-guided construct design; isotope-labeling strategy; E. coli/yeast expression in minimal media

Deliverable: Expression strategy + labeling report

02 Purification & QC

  • NanoDSF/DLS quality gates; IMAC/SEC purification; NMR sample preparation (0.3–0.5 mM)

Deliverable: Purified labeled protein with yield documentation

03 Data Collection

  • NUS-accelerated HSQC, NOESY, TROSY; automated acquisition via SampleJet; real-time spectral quality monitoring

Deliverable: Raw spectral dataset (TopSpin format)

04 AI Assignment

  • ARTINA deep learning peak picking; GNN chemical shift refinement; automated NOESY assignment

Deliverable: Chemical shift assignment table (BMRB-ready)

05 Structure/Dynamics

  • CYANA/CNS structure calculation; AlphaFold3 ensemble refinement; relaxation/dynamics analysis

Deliverable: Structural ensemble + dynamics report

06 Validation & Handoff

  • BMRB deposition; PDB ensemble submission; dynamics report; handoff to SBDD or MD

Deliverable: Final report + data package + transition plan

Sample Requirements

Sample Type Specification
Protein/Peptide >95% purity; >0.3 mM in 50 µL (1.7 mm tube) or 300 µL (5 mm tube); NanoDSF Tm >35°C; DLS PDI <1.2
Isotope Labeling ¹³C/¹⁵N required for structure determination; ²H-labeling for proteins >30 kDa; selective methyl labeling (ILV) for very large complexes
Fragment Library 10 mM DMSO stock; aqueous solubility >50 µM; purity >95%
Prior Data Any known chemical shifts (BMRB format); previous homology models; expected binding site information

Standard Deliverables

Upon project completion, clients receive comprehensive experimental reports including:

  • Chemical shift assignments (BMRB format) with AI confidence scores
  • 3D structural ensemble (PDB format) with distance and dihedral restraint lists
  • Relaxation and dynamics reports (R₁, R₂, heteronuclear NOE, CPMG dispersion)
  • Fragment binding epitope maps and K_D values (STD-NMR/SHARPER)
  • Molecular Docking-ready ensemble coordinates
  • Direct handoff to Molecular Docking, MD Simulation, or Lead Optimization
Ready to Characterize Your Target in Solution?
From FASTA to dynamic ensemble — without building an NMR center.

Our technical team responds within 24 hours. All inquiries protected under NDA.

Frequently Asked Questions

Case Study

Case: Structural Characterization of Target Peptide by NMR

Goal: Determine the three-dimensional solution structure of a customer-provided target peptide through isotope-labeled recombinant expression and multidimensional NMR spectroscopy, delivering an atomic-resolution conformational model to support peptide-based drug design.

Key Data:

  • NMR Data Collection: 3.3 mM peptide in THF-d₂/H₂O with DSS internal standard; ¹H-¹⁵N HSQC, ¹H-¹³C HSQC, TOCSY (80 ms), NOESY (200 ms) acquired at 25°C
  • Resonance Assignment: Sequential connectivity established via HN-Hα fingerprint and HN-HN NOE analysis; overall assignment rate >90%; C-terminal proline identified in two conformations (cis/trans), with cis conformation selected for structure calculation
  • Structure Calculation: 200 structures generated via CNS/Aria with NOE-derived distance restraints; 20 lowest-energy structures selected; no distance violations >0.5 Å or dihedral violations >5°
  • Structural Features: Residues 3–29 adopt a long α-helix; structure validated by Protein Structure Validation Suite (PSVS)

Why it matters: For peptide therapeutics and biologics programs, the solution-state conformation dictates receptor binding affinity and proteolytic stability. This case demonstrates our end-to-end capability — from gene synthesis and isotope labeling to multidimensional NMR and 3D structure calculation — delivering a validated structural ensemble without crystallization. For virtual biotechs, this eliminates the need to coordinate molecular biology, isotope fermentation, and spectroscopy vendors. For pharma, the >98% purity and complete assignment documentation support IND-enabling CMC packages.

1H-15N HSQC spectrum of target peptide with sequential resonance assignments.

Figure 1. 1H-15N HSQC spectrum with sequential resonance assignments. C-terminal proline cis/trans conformations labeled in blue.

3D structural ensemble of target peptide showing long alpha-helical conformation.

Figure 2. 3D structural ensemble of the target peptide. Residues 3–29 form a long α-helix.

HPLC chromatogram confirming target peptide purity greater than 98 percent.

Figure 3. Analytical HPLC confirming peptide purity of 98.03%.

Need AI-enhanced NMR spectroscopy to accelerate your fragment-based or structural biology program? Our team can design a customized NMR pipeline tailored to your target class, labeling constraints, and regulatory milestones. Contact our scientific team today.